Cardiol Therapeutics Inc.

NASDAQ: CRDL · Real-Time Price · USD
1.31
-0.03 (-2.24%)
At close: Aug 15, 2025, 12:14 PM

Cardiol Therapeutics Balance Sheet Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.58M 34.93M 59.47M 83.9M
Short-Term Investments
n/a 61.88K 61.88K 61.57K
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -0.00 -0.00
Receivables
361.62K n/a n/a 407.13K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 279.87K n/a n/a
Total Current Assets
31.67M 36.15M 61.44M 87.14M
Property-Plant & Equipment
195.59K 337.06K 295.74K 356.49K
Goodwill & Intangibles
n/a 210.36K 294.8K 379.25K
Total Long-Term Assets
195.59K 547.42K 590.54K 735.74K
Total Assets
31.86M 36.7M 62.03M 87.88M
Account Payables
6.98M 7.62M 8.35M 4.14M
Deferred Revenue
n/a n/a -8.35M -4.19M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a 238.18K 419.9K 6.66M
Total Current Liabilities
7.01M 8.3M 9.8M 11.57M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
125.52K 158.53K 22.42K 72.87K
Total Liabilities
7.14M 8.45M 9.83M 11.64M
Total Debt
158.53K 174.34K 72.87K 117.58K
Common Stock
179.34M 148.52M 147.55M 142.92M
Retained Earnings
-179.25M -142.58M -114.45M -83.52M
Comprehensive Income
n/a 3.52M 3.52M 4.18M
Shareholders Equity
24.73M 28.25M 52.2M 76.24M
Total Investments
n/a 61.88K 61.88K 61.57K